SHR-A2009: Clinical Trials

3 trials of SHR-A2009, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 not yet recruiting. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Recruiting 2, Not yet recruiting 1

Follow SHR-A2009: new trials by email Literature Review of SHR-A2009 trials Research Report on SHR-A2009

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Platform Study of ADC Rechallenge in ADC-treated Metastatic Breast Cancer
SHR-A1811, SHR-A1921, SHR-A2009 - Advanced Breast Cancer, Metastatic Breast Cancer
Phase 2RecruitingFudan University1602024-10-212026-09-03
Clinical Study of SHR-A1921 or SHR-A2009 in Previously Treated Advanced NSCLC
SHR-A2009, SHR-A1921 - NSCLC
Phase 2Not yet recruitingHenan Cancer Hospital302024-06-012024-06-20
SNF Platform Study of HR+/ HER2-advanced Breast Cancer
PIK3CA inhibitor, AKT inhibitor, Carrelizumab - Breast Neoplasm, Breast Cancer
Phase 2RecruitingFudan University6202022-12-302024-10-04

Conditions studied

Breast Neoplasms (2)  ·  Triple Negative Breast Neoplasms (1)

Sponsors

Fudan University (2)  ·  Henan Cancer Hospital (1)

Countries

China (3)

Top investigators

Zhimin Shao, M.D. (1)